Genascence Corporation

Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskeletal diseases

Add To Watchlist
General Information
Company Name
Genascence Corporation
Founded Year
2017
Location (Offices)
Founders / Decision Makers
Thomas W. Chalberg, PhD - Founder/CEO Lachy McLean - Chief Medical Officer
Number of Employees
7
Industries
Biotechnology
Funding Stage
Grant
Social Media

Genascence Corporation - Company Profile

Genascence Corporation is a clinical-stage biotechnology company that was founded in 2017. The company is dedicated to revolutionizing the treatment for musculoskeletal diseases through the development of life-changing gene therapy products. In February 2023, the company received a significant $11.60M grant investment from the California Institute for Regenerative Medicine.

Taxonomy: gene therapy, musculoskeletal diseases, clinical-stage, life-changing, treatment development, innovation, medical research, regenerative medicine

Funding Rounds & Investors of Genascence Corporation (3)

View All
Funding Stage Amount No. Investors Investors Date
Grant $11.60M 1 California Institute for Regenerative Medicine 23 Feb 2023
Series A $5.00M 1
Deepwork Capital, investor in Genascence Corporation's Series A round
01 Aug 2022
Series A $10.50M 4
Deepwork Capital, investor in Genascence Corporation's Series A round Polymerase Capital, investor in Genascence Corporation's Series A round
Pacira Pharmaceuticals, University of Florida Research Foundation 		07 Jan 2022

Latest News of Genascence Corporation

View All

No recent news or press coverage available for Genascence Corporation.

Similar Companies to Genascence Corporation

View All

No funding or investment information available for Genascence Corporation at this time.

Circle Decoration Circle Decoration

Want to dive deeper into Genascence Corporation? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now